Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial-Reference-Cited by-同舟云学术

Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial

Published:2014-11 Issue:9955 Volume:384 Page:1673-1683
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Rodger Marc A,Hague William M,Kingdom John,Kahn Susan R,Karovitch Alan,Sermer Mathew,Clement Anne Marie,Coat Suzette,Chan Wee Shian,Said Joanne,Rey Evelyne,Robinson Sue,Khurana Rshmi,Demers Christine,Kovacs Michael J,Solymoss Susan,Hinshaw Kim,Dwyer James,Smith Graeme,McDonald Sarah,Newstead-Angel Jill,McLeod Anne,Khandelwal Meena,Silver Robert M,Le Gal Gregoire,Greer Ian A,Keely Erin,Rosene-Montella Karen,Walker Mark,Wells Philip S

Funder

Canadian Institutes of Health Research

Heart and Stroke Foundation of Canada

Heart and Stroke Foundation of Ontario Career Investigator Award

Publisher

Elsevier BV

Subject

General Medicine

Reference45 articles.

1. The epidemiology of inherited thrombophilia: the VITA Project. Vicenza Thrombophilia and Atherosclerosis Project;Rodeghiero;Thromb Haemost,1997

2. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study;Heit;Ann Intern Med,2005

3. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium;Gerhardt;N Engl J Med,2000